Holding(s) in Company

RNS Number : 7901P
Dechra Pharmaceuticals PLC
31 March 2009
 




For filings with the FSA include the annex

For filings with issuer exclude the annex 


TR-1: Notifications of Major Interests in Shares


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Dechra Pharmaceuticals Plc

 

GB0009633180



2. Reason for notification (yes/no)


An acquisition or disposal of voting rights


X


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 



An event changing the breakdown of voting rights



Other (please specify): Transparency obligations directive - notification of existing previously disclosed position



3. Full name of person(s) subject to notification obligation:

Norges Bank


4. Full name of shareholder(s) (if different from 3):


N/A


5. Date of transaction (and date on which the threshold is crossed or reached if different):


27th March 2009


6. Date on which issuer notified:


30th March 2009


7. Threshold(s) that is/are crossed or reached:


3%



8: Notified Details                                                 Acquisition of shares increasing  

                                                                                   holding above the 3% threshold

A: Voting rights attached to shares


Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights


Direct


Indirect


Direct


Indirect

GB0009633180

1,963,363

1,963,363

1,966,224

1,966,224


3.00%





B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A

N/A

N/A


 

N/A

N/A



Total (A+B)


Number of voting rights

Percentage of voting rights

1,966,224

3.00%




9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:


N/A


Proxy Voting:


10. Name of proxy holder:


Norges Bank

11. Number of voting rights proxy holder will cease to hold:



N/A

12. Date on which proxy holder will cease to hold voting rights:



N/A


13. Additional information:


None

14 Contact name:


Robert Cook

15. Contact telephone number:


0047 24073120


For notes on how to complete form TR-1 please see the FSA website. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKGGFFRMVGLZG
UK 100

Latest directors dealings